 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Omnaris, others |
| Other names | (11β, 16α)-16, 17-[[(R)-cyclohexylmethylene]bis(oxy)]-11-hydroxy-21- (2-methyl-1-oxopropoxy)- pregna-1, 4-diene-3, 20-dione |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a607008 |
| Pregnancy category |
|
| Routes of administration | Nasal inhalation |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.210.908 |
| Chemical and physical data | |
| Formula | C32H44O7 |
| Molar mass | 540.697 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Ciclesonide, sold under the brand nameOmnaris among others, is aglucocorticoid used to treatasthma andallergic rhinitis.
Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.[6]
It was patented in 1990 and approved for medical use in 2005.[7] The drug was approved for adults and children 12 and over by the USFood and Drug Administration in October 2006.[8] It is on theWorld Health Organization's List of Essential Medicines.[9]
It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, Zetonna, and Alvesco for hay fever in the US and Canada.
